One in three (33%) U.S. adults who have been prescribed drugs to take regularly report that they are often or very often not compliant with their medications.
Medication compliance was a problem three years ago, as reported in a 2003 issue of MANAGED HEALTHCARE EXECUTIVE, and its weight can still be felt today. One in three (33%) U.S. adults who have been prescribed drugs to take regularly report that they are often or very often not compliant with their medications.
Although many reasons lie behind non-compliance, a study conducted by Wall Street Journal/Harris Interactive shows that 64% of respondents with drugs prescribed in the last year cite forgetfulness as the main reason for non-compliance; 45% are concerned about the medication; and 43% believe the drug is unnecessary. Other barriers to adherence, according to the study, include financial reasons, dangerous side effects, a belief that the drugs are ineffective and asymptomatic patients who do not perceive value from a drug.
These frightening statistics result in an additional $100 billion in healthcare costs annually, according to a study from The New England Journal of Medicine. On the upside, however, these data are pushing healthcare organizations to develop programs to promote medication compliance-from chronic illness self-management and reminders to education and "smart pill bottles."
Overall, the study shows that money spent on medication treatments results in substantial savings when the costs of adherence to drug therapy are compared with the costs of hospitalizations and visits to the emergency room and doctor's office.
"Health plans are reluctant to adopt compliance programs because they suspect they will be expensive," says Lon Castle, MD, director, medical policy and programs for Medco, "but the long-term benefits outweigh the costs."
Medco reaches out to non-compliant patients who may be refilling their prescriptions too soon, taking too much of a drug or not filling their prescriptions at all, as well as to their physicians through reminders.
PBMS RELY ON EDUCATION
Prescription Solutions Specialty Pharmacy Program has coordinated a program that combines mail service, home infusion, care and claim management and data tracking along with disease therapy management, which educates patients and their families/caregivers about drug regimens to achieve the best clinical outcomes and minimize therapy-related adverse events.
A Conversation With Greg Baker, RPh, CEO of AffirmedRx
March 31st 2024Greg Baker, CEO of AffirmedRx, describes his early career, shares some of his critical opinions about the pharmacy benefit management (PBM) industry and how, in his view, his company is offering a better alternative.
Read More
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
What Payers Need to Know As Retail Pharmacies Move Into Primary Care
September 6th 2023Healthcare beyond the doors of the doctor’s office has the potential to offer more care to more people. But payers need to think about how to ensure that care is consistent. Regardless of the setting, care decisions must be based on evidence-based content and supported with strong patient education.
Read More